islandpharmaceuticals

📰@People reports rising dengue cases flagged by CDC, highlighting the growing global risk from mosquito-borne diseases. 🦟 $ILA is advancing ISLA-101 for #dengue and Galidesivir, a broad-spectrum #antiviral active against 20+ RNA viruses. Full story: people.com/cdc-issues-tra…

Q: You have fairly extensive clinical trial experience. How do you see the next 12-18 months playing out for Island Pharmaceuticals? youtu.be/-n1bb6SaS9 $ILA $ILA.ax #ASX #biotech #antiviral #health

Q: Island Pharmaceuticals obviously received some unprecedented feedback from the US FDA in regard to its #Galidesivir #antiviral program, what do you see as the key risk for $ILA moving forward? youtu.be/-n1bb6SaS94 $ILA.ax #ASX #biotech

ICYMI via @InvestorStream_ Q: Daniel, you're a large shareholder in $ILA, having supported the company through a placement and an options exercise. What was it that attracted you to the company and where do you see the near-term opportunity? youtu.be/-n1bb6SaS94 #ASX #biotech

Q: You have fairly extensive clinical trial experience. How do you see the next 12-18 months playing out for Island Pharmaceuticals? youtu.be/-n1bb6SaS9 $ILA $ILA.ax #ASX #biotech #antiviral #health

Q: Island Pharmaceuticals obviously received some unprecedented feedback from the US FDA in regard to its #Galidesivir #antiviral program, what do you see as the key risk for $ILA moving forward? youtu.be/-n1bb6SaS94 $ILA.ax #ASX #biotech

Via @InvestorStream_ Q: Daniel, you're a large shareholder in $ILA, having supported the company through a placement and an options exercise. What was it that attracted you to the company and where do you see the near-term opportunity? youtu.be/-n1bb6SaS94 #ASX #biotech

$ILA commenced research collaboration w/ @BurnetInstitute to expand development pathways for #ISLA101 & #Galidesivir. Program will assess activity against measles, chikungunya & Ross River virus, aligning w/ global health security & #biodefence priorities. islandpharmaceuticals.com/site/pdf/17e28…

$ILA commenced research collaboration w/ @BurnetInstitute to expand development pathways for #ISLA101 & #Galidesivir. Program will assess activity against measles, chikungunya & Ross River virus, aligning w/ global health security & #biodefence priorities. islandpharmaceuticals.com/site/pdf/17e28…

Q: Looking ahead, collaboration will involve new non-human primate studies required for potential approval under FDA’s Animal Rule. What are key milestones investors should be watching over next 6-12 months as program advances? youtu.be/8yEvmeqeS80 #biotech $ILA #health

Q: The Institute previously supported #Galidesivir, including NHP studies showing strong survival in #Ebola and #Marburg models. How does this new agreement build on that work and help de-risk the pathway from here? youtu.be/8yEvmeqeS80 $ILA $ILA.ax #ASX #biotech #health

📺 ICYMI Q: David, welcome back to @InvestorStream_. You’ve formalised a CRADA with USAMRIID and The Geneva Foundation. How important is this in accelerating #Galidesivir toward FDA Animal Rule approval for #Marburg? youtu.be/8yEvmeqeS80 $ILA $ILA.ax

Q: Looking ahead, collaboration will involve new non-human primate studies required for potential approval under FDA’s Animal Rule. What are key milestones investors should be watching over next 6-12 months as program advances? youtu.be/8yEvmeqeS80 #biotech $ILA #health

Q: The Institute previously supported #Galidesivir, including NHP studies showing strong survival in #Ebola and #Marburg models. How does this new agreement build on that work and help de-risk the pathway from here? youtu.be/8yEvmeqeS80 $ILA $ILA.ax #ASX #biotech #health

📺 Q: David, welcome back to @InvestorStream_. You’ve formalised a CRADA with USAMRIID and The Geneva Foundation. How important is this in accelerating #Galidesivir toward FDA Animal Rule approval for #Marburg? youtu.be/8yEvmeqeS80 $ILA $ILA.ax

$ILA signs CRADA w/ USAMRIID & The Geneva Foundation to accelerate #Galidesivir under FDA Animal Rule for Marburg Virus Disease. Collaboration advances NHP studies toward potential NDA approval, building on prior #Ebola & #Marburg data. islandpharmaceuticals.com/site/pdf/5814c… #ASX #Biodefense

From the @InvestorStream_ desk: 📢@IslandPharma $ILA signs CRADA w/ USAMRIID & The Geneva Foundation to advance #Galidesivir under FDA Animal Rule for Marburg 🧪US DoD’s top infectious disease institute to support NHP studies toward potential NDA 📈SP +10.81% on ~828K shares #ASX

$ILA signs CRADA w/ USAMRIID & The Geneva Foundation to accelerate #Galidesivir under FDA Animal Rule for Marburg Virus Disease. Collaboration advances NHP studies toward potential NDA approval, building on prior #Ebola & #Marburg data. islandpharmaceuticals.com/site/pdf/5814c… #ASX #Biodefense

Q: As you advance clinical development, what are the biggest regulatory risks remaining and what steps is the company taking to mitigate them? WEBINAR: youtu.be/clMeX30iwXs $ILA #health #biotech #ASX

Q:. Is the company still able to ascertain government contracts during the NDA review process? WEBINAR: youtu.be/clMeX30iwXs $ILA #health #biotech #ASX